Abstract:In 2023, cholera affected approximately 1 million people and caused more than 5000 deaths globally, predominantly in low-income and conflict settings. In recent years, the number of new cholera outbreaks has grown rapidly. Further, ongoing cholera outbreaks have been exacerbated by conflict, climate change, and poor infrastructure, resulting in prolonged crises. As a result, the demand for treatment and intervention is quickly outpacing existing resource availability. Prior to improved water and sanitation systems, cholera — a disease primarily transmitted via contaminated water sources — also routinely ravaged high-income countries. Crumbling infrastructure and climate change are now putting new locations at risk — even in high-income countries. Thus, understanding the transmission and prevention of cholera is critical. Combating cholera requires multiple interventions, the most common being behavioral education and water treatment. Two-dose oral cholera vaccination (OCV) is often used as a complement to these interventions. Due to limited supply, countries have recently switched to single-dose vaccines (OCV1). One challenge lies in understanding where to allocate OCV1 in a timely manner, especially in settings lacking well-resourced public health surveillance systems. As cholera occurs primarily in low-income and conflict settings, timely, accurate, and openly accessible outbreak data are typically inaccessible for disease modeling and subsequent decision-making. In this study, we demonstrated the value of open-access data to rapidly estimate disease transmission and vaccine effectiveness. Specifically, we obtained non-machine readable (NMR) epidemic curves for recent cholera outbreaks in two countries, Haiti and Cameroon, from figures published in situation and disease outbreak news reports. We used computational digitization techniques to derive weekly counts of cholera cases. Given these data, we leveraged EpiEstim — an open-source modeling platform — to derive rapid estimates of time-varying disease transmission via the effective reproduction number (R ). We used VaxEstim, a recent extension of this platform allowing the estimation of vaccine effectiveness via the relation between the basic reproductive number (R ), R , and vaccine coverage, to compare OCV1 effectiveness in the two considered countries. Here, with Haiti and Cameroon as case studies, we demonstrated the first implementation of VaxEstim in low-resource settings. In the initial phase of the outbreak, weekly rolling average estimates of R were elevated in both countries: 2.60 in Haiti [95% credible interval: 2.42-2.79] and 1.90 in Cameroon [1.14-2.95]. Similarly, in both countries, this period of high transmission preceded a longer period during which R oscillated around the critical threshold of 1. VaxEstim results suggest that Haiti had higher OCV1 effectiveness than Cameroon (75.32% effective [54.00-86.39%] vs. 56.21% [18.87-84.94%]). This work underscores the value of combining NMR sources of outbreak case data with computational techniques and the utility of VaxEstim for rapid, inexpensive estimation of vaccine effectiveness in data-poor outbreak settings.

Systematic testing in cholera surveillance enhances vaccine impact and cost-effectiveness

Enhanced cholera surveillance to improve vaccination campaign efficiency

The projected impact of geographic targeting of oral cholera vaccination in sub-Saharan Africa: A modeling study

Optimizing immunization schedules in endemic cholera regions: cost-effectiveness assessment of vaccination strategies for cholera control in Bangladesh

Vaccination strategies for epidemic cholera in Haiti with implications for the developing world

Improving immunization approaches to cholera

Controlling Endemic Cholera with Oral Vaccines

The Case for Reactive Mass Oral Cholera Vaccinations

Impact of a multi-pronged cholera intervention in an endemic setting

Impact of oral cholera vaccines in cholera-endemic countries: A mathematical modeling study

Lessons learnt from 12 oral cholera vaccine campaigns in resource-poor settings

Considerations around the introduction of a cholera vaccine in Bangladesh

Evaluation of Targeted Mass Cholera Vaccination Strategies in Bangladesh: A Demonstration of a New Cost-Effectiveness Calculator

A Quantitative Systematic Review and Meta-Analysis of the Effectiveness of Oral Cholera Vaccine as a Reactive Measure in Cholera Outbreaks

Estimating time-varying transmission and oral cholera vaccine effectiveness in Haiti and Cameroon, 2021-2023

The Costs and Cost-Effectiveness of a Two-Dose Oral Cholera Vaccination Campaign: A Case Study in a Refugee Camp Setting in Thailand

Global economic evaluation of oral cholera vaccine: A systematic review

Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study

Oral cholera vaccine in cholera prevention and control, Malawi

Evaluation of a rapid diagnostic test for detection of Vibrio cholerae O1 in the Democratic Republic of the Congo: Preventative intervention for cholera for 7 days (PICHA7 program)

Cholera in disasters: do vaccines prompt new hopes?